This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vanderlaan, R. D. Articles by Backx, P. H. Search for Related Content PubMed PubMed Citation Articles by Vanderlaan, R. D. Articles by Backx, P. H. Related Collections Electrophysiology Cardiovascular Pharmacology Arrythmias-basic studies Ion channels/membrane transport Cardiac development

(Circulation Research. 2003;93:1.)
© 2003 American Heart Association, Inc.

Editorials

Electrophysiological Profiling of Cardiomyocytes in Embryonic Bodies Derived From Human Embryonic Stem Cells

Therapeutic Implications

Rachel D. Vanderlaan, Gavin Y. Oudit, Peter H. Backx

From the Departments of Medicine and Physiology, Heart and Stroke/Richard Lewar Centre of Excellence, University of Toronto, Ontario, Canada.

Correspondence to Dr Peter H. Backx, DVM, PhD, Heart and Stroke/Richard Lewar Centre of Excellence, 150 College St, Room 68, Fitzgerald Building, Toronto, Ontario, M5S 3E2. E-mail p.backx@utoronto.ca

Key Words: embryonic stem cells • embryonic bodies • electrophysiology • cardiomyocytes • action potentials

An extract of the first 250 words of the full text is provided, because this article has no abstract.

Human embryonic stem (hES) cells are derived from the inner mass cells of developing blastocytes and have the ability to generate cells from three embryonic germ layers. Since their initial culturing in 1981, ES cells have revolutionized the mouse genetics field^1,2 by allowing the creation of mouse models of disease as well as the molecular study of the differentiation of pluripotent cells into various somatic cell types including cardiomyocytes and vascular smooth cells.^3–5 Some key features of ES cells that have made them particularly useful in research include their ability for self-renewal, diploid karyotype stability, and continuous telomerase activity.^6–9 Since human fetuses are not generally available for scientific study, hES cells represent an in vitro model for embryonic differentiation, with the ability to understand more about cell lineage commitment and the process of differentiation. Importantly, they also represent a potential source of cells for therapeutic uses such as the regeneration of functional myocardium and conducting tissue. As a consequence of these capabilities and their derivation from human embryos, hES cells have been a subject of numerous ethical and moral debates.¹⁰

In this issue of Circulation Research, He and coworkers characterize the electrophysiological and contractile properties of cardiomyocytes derived from hES cells.¹¹ This work, together with previous studies by Gepstein’s group^8,12 and other recent reports,^13,14 expands our understanding of cardiac differentiation of hES cells, building a foundation for future research and for new therapeutic strategies using hES cells. In agreement with other hES studies,⁸ He et al found that about . . . [Full Text of this Article]

This article has been cited by other articles:

				J. C. Davila, G. G. Cezar, M. Thiede, S. Strom, T. Miki, and J. Trosko Use and Application of Stem Cells in Toxicology Toxicol. Sci., June 1, 2004; 79(2): 214 - 223. [Abstract] [Full Text] [PDF]